Retrospective Study
Copyright ©The Author(s) 2023.
World J Hepatol. Mar 27, 2023; 15(3): 431-440
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.431
Table 2 Select disease-specific characteristics in patients with coexistent disease vs alcohol-related liver cirrhosis only, n (%)
Characteristics present
CD (n = 133)
ALC only (n = 135)
P value
Verification criteria fulfilled
Liver biopsy performed22 (17)45 (33)0.002
Cirrhosis on biopsy13 (59)22 (49)0.349
Cirrhosis on imagingb101 (76)126 (93)< 0.001
Portal hypertension features on imaging78 (59)100 (74)0.006
Alcohol-Related hepatitis48 (36)34 (25)0.052
MELD scorea19.3 ± 8.9818.7 ± 8.890.614
Child-Pugh scorea0.69
A41 (31)48 (36)
B49 (39)48 (36)
C43 (32)39 (29)
Complications of portal hypertension
Esophageal varices on EGD46 (35)68 (50)< 0.001
Esophageal variceal hemorrhage11 (8)17 (13)0.247
Ascites96 (72)83 (62)0.063
Spontaneous bacterial peritonitis22 (17)9 (7)0.011
Portosystemic encephalopathy62 (47)68 (50)0.539
Hepatocellular carcinoma6 (5)23 (17)0.001
End-stage renal disease requiring CRRT/HD15 (11)13 (10)0.644
Treatment of portal hypertension/complications
Esophageal variceal banding11 (8)22 (16)0.046
TIPS3 (2)8 (6)0.13
Beta-blocker usea18 (14)38 (28)0.004
Diuretic usea57 (43)65 (48)0.415
Large volume paracentesis29 (22)39 (29)0.183
Antibiotics for SBP prophylaxisa9 (7)11 (8)0.68
Lactulose and/or rifaximin usea50 (38)55 (41)0.632
Transplant evaluation14 (11)19 (14)0.402
Liver transplantation3 (2)10 (7)0.05